282 related articles for article (PubMed ID: 29974234)
21. Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 in Gallbladder Carcinoma.
Kim SJ; Kim SW; Oh CH; Hong M; DO SI; Kim YW; Kim HS; Na K
Anticancer Res; 2020 Oct; 40(10):5777-5785. PubMed ID: 32988905
[TBL] [Abstract][Full Text] [Related]
22. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
23. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.
Gertler R; Stein HJ; Schuster T; Rondak IC; Höfler H; Feith M
Ann Surg; 2014 Jan; 259(1):96-101. PubMed ID: 24096772
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
Chromecki TF; Cha EK; Pummer K; Scherr DS; Tewari AK; Sun M; Fajkovic H; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
BJU Int; 2012 Jul; 110(1):63-8. PubMed ID: 22077633
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
[TBL] [Abstract][Full Text] [Related]
27. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
29. IMP3 Immunoreactivity is More Sensitive Than AMACR in Detecting Dysplastic Epithelium and Early Adenocarcinoma in Barrett Esophagus.
Gadara MR; Gonzalez M; Cartun RW; Ligato S
Appl Immunohistochem Mol Morphol; 2017 Jul; 25(6):386-391. PubMed ID: 26766126
[TBL] [Abstract][Full Text] [Related]
30. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
[TBL] [Abstract][Full Text] [Related]
31. An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia.
Lu D; Vohra P; Chu PG; Woda B; Rock KL; Jiang Z
Am J Surg Pathol; 2009 Apr; 33(4):521-5. PubMed ID: 19047899
[TBL] [Abstract][Full Text] [Related]
32. Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus.
Langer R; Feith M; Siewert JR; Wester HJ; Hoefler H
BMC Cancer; 2008 Mar; 8():70. PubMed ID: 18331622
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor-II mRNA-binding protein 3 expression in effusion cytology: a marker for metastatic adenocarcinoma cells and a potential prognostic indicator in gastric adenocarcinoma.
Kim HJ; Kim GE; Lee JS; Lee JH; Nam JH; Choi C
Acta Cytol; 2014; 58(2):167-73. PubMed ID: 24457229
[TBL] [Abstract][Full Text] [Related]
34. [Lymph node metastasis and prognostic factors for T1 esophageal cancer].
Duan XF; Shang XB; Tang P; Jiang HJ; Gong L; Yue J; Ma MQ; Yu ZT
Zhonghua Wai Ke Za Zhi; 2017 Sep; 55(9):690-695. PubMed ID: 28870055
[No Abstract] [Full Text] [Related]
35. LKB1 inactivation occurs in a subset of esophageal adenocarcinomas and is sufficient to drive tumor cell proliferation.
Whitsett TG; Mittal SK; Eschbacher JM; Carson VM; Smith MA; Bremner RM; Inge LJ
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1891-1899. PubMed ID: 29370903
[TBL] [Abstract][Full Text] [Related]
36. TGM2: a cell surface marker in esophageal adenocarcinomas.
Leicht DT; Kausar T; Wang Z; Ferrer-Torres D; Wang TD; Thomas DG; Lin J; Chang AC; Lin L; Beer DG
J Thorac Oncol; 2014 Jun; 9(6):872-81. PubMed ID: 24828664
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor-II mRNA-binding protein 3 immunocytochemical expression in direct endometrial brushings: Possible diagnostic help in endometrial cytology.
Norimatsu Y; Yanoh K; Maeda Y; Irino S; Hirai Y; Fulciniti F; Kobayashi TK
Cytopathology; 2019 Mar; 30(2):215-222. PubMed ID: 30614088
[TBL] [Abstract][Full Text] [Related]
38. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
[TBL] [Abstract][Full Text] [Related]
39. Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.
Grupp K; Hofmann B; Kutup A; Bachmann K; Bogoevski D; Melling N; Uzunoglu FG; El Gammal AT; Koop C; Simon R; Steurer S; Krech T; Burdak-Rothkamm S; Jacobsen F; Sauter G; Izbicki J; Wilczak W
BMC Cancer; 2018 Nov; 18(1):1106. PubMed ID: 30419865
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.
von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M
Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
